2023-2024 Regular Session • Delaware Legislature

HB15: An Act To Amend Title 18 Of The Delaware Code Relating To Ovarian Cancer.

Legislative Summary

This Act requires all individual, blanket, and group health insurance policies to cover annual ovarian cancer screening tests for women at risk for ovarian cancer. It further expands the scope of monitoring tests available to women subsequent to ovarian cancer treatment.

Bill History

2/29/2024

Introduced and Assigned to Health & Human Development Committee in House

3/13/2024

Reported Out of Committee (Health & Human Development) in House with 10 Favorable, 2 On Its Merits

3/14/2024

Amendment HA 1 to HB 15 - Introduced and Placed With Bill

3/19/2024

Amendment HA 1 to HB 15 - Passed In House by Voice Vote

3/19/2024

Passed By House. Votes: 39 YES 2 ABSENT

3/19/2024

Assigned to Health & Social Services Committee in Senate

3/20/2024

Reported Out of Committee (Health & Social Services) in Senate with 7 Favorable

3/21/2024

Passed By Senate. Votes: 21 YES

3/21/2024

Signed by Governor

Roll Call Votes

Senate Third Reading

3/21/2024

Yea

Nay

Not Voting

Absent

Result: PASSED

House Third Reading

3/19/2024

Yea

Nay

Not Voting

Absent

Result: PASSED

Status Information

Current Status

Passed(3/21/2024)

Chamber

House of Representatives

Sine DiePrior Session

HB15: An Act To Amend Title 18 Of The Delaware Code Relating To Ovarian Cancer.

Legislative Summary

Bill History

Roll Call Votes

Status Information

Sponsors

Primary Sponsor

Co-Sponsors (35)

Documents

External Links